Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Dec 12;19(1):320.
doi: 10.1186/s12883-019-1536-7.

Delayed diagnosis of X-linked agammaglobulinaemia in a boy with recurrent meningitis

Affiliations
Case Reports

Delayed diagnosis of X-linked agammaglobulinaemia in a boy with recurrent meningitis

Ya-Ni Zhang et al. BMC Neurol. .

Abstract

Background: X-linked agammaglobulinaemia (XLA) is a rare inherited primary immunodeficiency disease characterized by the B cell developmental defect, caused by mutations in the gene coding for Bruton's tyrosine kinase (BTK), which may cause serious recurrent infections. The diagnosis of XLA is sometimes challenging because a few number of patients have higher levels of serum immunoglobulins than expected. In this study, we reported an atypical case with recurrent meningitis, delayed diagnosis with XLA by genetic analysis at the second episode of meningitis at the age of 8 years.

Case report: An 8-year-old Chinese boy presented with fever, dizziness and recurrent vomiting for 3 days. The cerebrospinal fluid (CSF) and magnetic resonance imaging (MRI) results were suggestive of bacterial meningoencephalitis, despite the negative gram staining and cultures of the CSF. The patient was treated with broad-spectrum antibiotics and responded well to the treatment. He had history of another episode of acute pneumococci meningitis 4 years before. The respective level of Immunoglobulin G (IgG), Immunoglobulin A (IgA) and Immunoglobulin M (IgM) was 4.85 g/L, 0.93 g/L and 0.1 g/L at 1st episode, whereas 1.9 g/L, 0.27 g/L and 0 g/L at second episode. The B lymphocytes were 0.21 and 0.06% of peripheral blood lymphocytes at first and second episode respectively. Sequencing of the BTK coding regions showed that the patient had a point mutation in the intron 14, hemizyous c.1349 + 5G > A, while his mother had a heterozygous mutation. It was a splice site mutation predicted to lead to exon skipping and cause a truncated BTK protein.

Conclusion: Immunity function should be routinely checked in patients with severe intracranial bacterial infection. Absence of B cells even with normal level of serum immunoglobulin suggests the possibility of XLA, although this happens only in rare instances. Mutational analysis of BTK gene is crucial for accurate diagnosis to atypical patients with XLA.

Keywords: Bruton’s tyrosine kinase; Children; Meningitis; Recurrent; X-linked agammaglobulinemia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Brain MRI during the two episodes of intracranial infection. A: FLAIR image revealed a little subdural effusion of left frontal, parietal-temporal areas and right frontal area. (1st episode). B: T2-weighted MRI image showedhigh-signal intensity in thickened mucosa of bilateralmaxillary sinus and mastoid process. (1st episode). C: FLAIR image showed high signal on right putamen. (2nd episode). D: Contrast enhanced T1-weighted imagesshowedenhancement of right putamen lesion and bilateral frontal and left temporal lobar meninge. (2nd episode). E: T2-weighted MRI image showedhigh-signal intensity in thickened mucosa of bilateral lethmoidal sinus. (2nd episode)
Fig. 2
Fig. 2
Direct sequence analysis of blood samples from the patient and his parents with reverse sequence

Similar articles

Cited by

References

    1. Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency. J Clin Immunol. 2015;35:696–726. doi: 10.1007/s10875-015-0201-1. - DOI - PMC - PubMed
    1. Conley ME. NotarangeloLD, EtzioniA. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies) Clin Immunol. 1999;93:190–197. doi: 10.1006/clim.1999.4799. - DOI - PubMed
    1. Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia:an Italian multicenter study. Clin Immunol. 2002;104:221–230. doi: 10.1006/clim.2002.5241. - DOI - PubMed
    1. Carrillo-Tapia E, García-García E, Herrera-González NE, Yamazaki-Nakashimada MA, Staines-Boone AT, Segura-Mendez NH, et al. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains. Expert Rev Clin Immunol. 2018;14:83–93. doi: 10.1080/1744666X.2018.1413349. - DOI - PubMed
    1. Kanegane H, Futatani T, Wang Y, Nomura K, Shinozaki K, Matsukura H, Kubota T, Tsukada S, Miyawaki T. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis. J Allergy Clin Immunol. 2001;108(6):1012–1020. doi: 10.1067/mai.2001.120133. - DOI - PubMed

Publication types

Substances

Supplementary concepts

LinkOut - more resources

  NODES
chat 1
INTERN 1
twitter 2